Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands.

MLA

Kwakman, Johannes J. M., et al. “Feasibility and Effectiveness of Trifluridine/Tipiracil in Metastatic Colorectal Cancer: Real-Life Data from The Netherlands.” International Journal of Clinical Oncology, vol. 23, no. 3, June 2018, pp. 482–89. EBSCOhost, https://doi.org/10.1007/s10147-017-1220-0.

APA

Kwakman, J. J. M., Vink, G., Vestjens, J. H., Beerepoot, L. V., de Groot, J. W., Jansen, R. L., Opdam, F. L., Boot, H., Creemers, G. J., van Rooijen, J. M., Los, M., Vulink, A. J. E., Schut, H., van Meerten, E., Baars, A., Hamberg, P., Kapiteijn, E., Sommeijer, D. W., Punt, C. J. A., & Koopman, M. (2018). Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands. International Journal of Clinical Oncology, 23(3), 482–489. https://doi.org/10.1007/s10147-017-1220-0

Chicago

Kwakman, Johannes J. M., G. Vink, J. H. Vestjens, L. V. Beerepoot, J. W. de Groot, R. L. Jansen, F. L. Opdam, et al. 2018. “Feasibility and Effectiveness of Trifluridine/Tipiracil in Metastatic Colorectal Cancer: Real-Life Data from The Netherlands.” International Journal of Clinical Oncology 23 (3): 482–89. doi:10.1007/s10147-017-1220-0.